FindTrial
Sign In

Comparison of the efficacy of combined endoscopic therapy and simple drug therapy for Forrest IIb peptic ulcer bleeding: a retrospective study based on medical records

Comparison of the efficacy of combined endoscopic therapy and simple drug therapy for Forrest IIb peptic ulcer bleeding: a retrospective study based on medical records.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027302
Enrollment
Unknown
Registered
2019-11-08
Start date
2019-11-30
Completion date
Unknown
Last updated
2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Forrest IIb peptic ulcer bleeding

Interventions

Combined endoscopic treatment group:Drug combined with endoscopic treatment
Simple drug group:medication treatment

Sponsors

Nanfang Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Vomiting blood, melena, gastric tube leading out bright red blood, bloody stool, and hemoglobin decreased by 2g/dl or more; 2. Gastroscopy is clearly a patient with FIIb ulcer bleeding; 3. Aged >= 18 years; 4. Has received drugs treatment or endoscopic treatment of patients.

Exclusion criteria

Exclusion criteria: 1. Patients with malignant tumor bleeding; 2. Patients who have undergone endoscopic treatment or data are unknown; 3. Patients with FIa, FIb, FIIa ulcers.

Design outcomes

Primary

MeasureTime frame
Rebleeding rate;—

Countries

China

Contacts

Public ContactBai Yang

Nanfang Hospital, Southern Medical University

13925001665@163.com+86 13925001665

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026